NCT03658629 - Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults | Biotech Hunter

Enrollment

1,375

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

April 26, 2019

Study Completion Date

April 26, 2019

Conditions

Influenza, Human

Interventions

BIOLOGICAL

NanoFlu (Quad-NIV)

2018-2019 Investigational Quadrivalent Seasonal Influenza Vaccine

OTHER

Matrix-M Adjuvant

Adjuvant

OTHER

Placebo

BIOLOGICAL

Fluzone HD

2018-2019 Licensed Trivalent Seasonal Influenza Vaccine

BIOLOGICAL

Flublok Quadrivalent

2018-2019 Licensed Quadrivalent Seasonal Influenza Vaccine

BIOLOGICAL

Influenza Vaccine

2018-19 Licensed Seasonal Influenza Vaccine

Trial Locations (14)

20854

US138, Rockville

27103

US063, Winston-Salem

27518

US078, Cary

27609

US108, Raleigh

28144

US137, Salisbury

28401

US071, Wilmington

28625

US132, Statesville

29461

US056, Moncks Corner

30281

US013, Stockbridge

31406

US045, Savannah

33024

US135, Hollywood

57049

US050, Dakota Dunes

68134

US018, Omaha

68701

US025, Norfolk